CHICAGO, Dec 7 - A hot new field of genetic therapy known as RNA interference may offer new approaches to medicine down the road, but Merck & Co Inc is putting the technology to work...
Chr Hansen has signed a service agreement with ProteoNic, which it believes will enable it to increase its protein yield, save on production costs, and improve competitiveness in dairy enzymes...